News

ER opioid prescriptions for low back pain cut in half, study finds
Results show that NSAIDs like ibuprofen are now the prescription painkiller of choice, provided to nearly 29% of low back ...
Clinical Pain Advisor5h
OUD Risk Increases With Higher Opioid Dose, Longer Duration in Musculoskeletal Pain
Patients with newly diagnosed musculoskeletal pain who received opioids at higher doses for longer durations had increased risk for OUD.
KALW6d
Why a new opioid alternative is out of reach for some pain patients
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug ...
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
FDA Protocol Review Completed ~ ~ Rho, Inc. Selected as Clinical Research Partner ~ SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company" ...